Oncolytics Biotech (ONCY)
(Delayed Data from NSDQ)
$0.86 USD
-0.06 (-6.20%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $0.86 0.00 (0.19%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth D Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, Oncolytics Biotech Inc. has a market cap of $89.14M, which represents its share price of $0.92 multiplied by its outstanding shares number of 97.41M. As a small-cap company, ONCY's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
ONCY 0.86 -0.06(-6.20%)
Will ONCY be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ONCY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ONCY
Oncolytics Biotech (ONCY) Loses -9.34% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Oncolytics Biotech (ONCY) Upgraded to Buy: What Does It Mean for the Stock?
ONCY: What are Zacks experts saying now?
Zacks Private Portfolio Services
ONCY Stock Up on Regulatory Update From Breast Cancer Program
Other News for ONCY
Oncolytics Biotech GAAP EPS of -$0.07
Oncolytics reports Q2 EPS (C$0.07) vs. (C$0.10) last year
Oncolytics voluntarily delists common shares from Toronto Stock Exchange